234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
Please send us these documents:
On-line MS-questionnaire completed by the patient »
Please send all information to:
Waddell Center for MS
Medical Arts Building
222 Piedmont Avenue, Suite 3200
Cincinnati, OH 45219
Phone: 513-475-8775
Fax: 513-475-7352 (Please put Attn: Kim DiPilla)
After all information has been received, a scheduling associate will contact the patient to set up an appointment.
Complete Listing of Ongoing Adult Clinical Trials »
Links to research sites of note:
National Institutes of Health »
ClinicalTrials.GOV »
US Department of Health and Human Services »
Food and Drug Administration »
Understanding Clinical Trials »
1. Waddell Center specialists offer a highly comprehensive, standardized diagnostic protocol to primary care physicians and general neurologists for their patients with a suspected diagnosis of MS.
Patients who present with first symptoms consistent with a demyelinating event should undergo an imaging study (ideally an MRI of the brain and/or spinal cord) to rule out alternative etiologies or causes, such as vascular events or a tumor. If the MRI is consistent with a demyelinating event, Waddell Center specialists will perform the rest of the diagnostic work-up if the patient is referred to them.
The advantages of performing a diagnostic work-up at the Waddell Center are:
The Waddell Center has a streamlined screening process for referred patients. (See our online questionnaire). Upon receiving the referral documentation (patient questionnaire and MRI data, plus any additional work-up the patient may have undergone) and determining that the patient has possible MS, a clinical visit with one of the Waddell Center specialists will be scheduled.
Polman, C.H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58, 840-846 (2005).
« back to goals
2. Waddell Center specialists offer consultation and services to physicians who care for MS patients who suffer from very active MS and who continue to accumulate disability despite FDA-approved disease-modifying therapies. Waddell clinicians can offer advice regarding the management of these MS patients or, at the request of the referring physician and patient, can provide therapeutic services until the patient’s disease has stabilized.
Waddell Center specialists also can provide information about therapeutic trials in the region that may be appropriate for, and of benefit to, the patient.
The Waddell Center has a streamlined screening process for referred patients (please see our on-line questionnaire). Upon receiving the referral documentation and MRI data and determining that the patient possibly has MS, a clinical visit with one of the Waddell Center specialists will be scheduled.
3. The Waddell Center is committed to improving the care and well-being of MS patients in the Greater Cincinnati area. We strive to collaborate closely with primary care physicians and neurologists in the community and with the Ohio Valley Chapter of the National MS Society in order to identify patient needs and to develop programs that address those needs.
As researchers, Waddell Center specialists are committed to focusing their research efforts in areas that are most lacking in development. As such, we are striving to:
4. Unfortunately, FDA-approved immunomodulatory therapies currently available do not provide sufficient therapeutic benefit for all MS patients. Use of the harsh immunosuppressive agents, although indicated in special cases with evidence of prominent destructive inflammation, may have additional deleterious effects on remyelination and repair. Therefore, new therapies with better risk/benefit ratios, and especially experimental therapies with neuroprotective potential, are urgently needed for patients who are experiencing unsatisfactory results from their treatments.
To facilitate the development and testing of such novel therapies in Greater Cincinnati, the Waddell Center is collecting data on patients with insufficient therapeutic response to FDA-approved therapies. Therefore, physicians caring for MS patients are encouraged to refer patients who are failing standard therapeutic options for evaluation at the Waddell Center. Patients also may indicate their wish to be considered for participation in MS research in the Greater Cincinnati area by filling out the Center’s on-line questionnaire and by indicating their wish to be included in the database of possible future trial participants.
5. As a part of our commitment to improving the lives of all MS patients in the Greater Cincinnati area, Waddell Center specialists provide lectures and updates on MS to community physicians, patients, families, and support groups.
Educational materials for patients and their caregivers developed for this Web page are part of this ongoing effort to promote and actively support MS awareness and education in the community.